verified SJR 2,344 · Q1 • database Scopus / SJR & Web of Science indexed

United States · John Wiley and Sons Inc

workspace_premium Q1 — Pharmacology lock Subscription

British Journal of Pharmacology

British Journal of Pharmacology is a journal indexed in SJR in Pharmacology with an H index of 252. It has a price of 3429 €. It has an SJR impact factor of 2,344 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,344.

British Journal of Pharmacology focuses its scope in these topics and keywords: effects, pharmacology, receptor, receptors, cardiovascular, rat, isolated, inhibitor, effect, channels, ...

ISSN: 0007-1188

Publisher: John Wiley and Sons Inc

Category: Pharmacology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

2,344 Q1

H-index 252

Acceptance rate pie_chart

19% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

3.429 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

2,344

H-index

252

Docs (year)

340

Docs 3y

859

Total refs

27697

Cites 3y

6162

Citable 3y

818

Cites/Doc 2y

7.09

Ref/Doc

81.46

Immediate OA

3429 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Binding of the prototypical adenosine A2Areceptor agonist CGS 21680 to the cerebral cortex of adenosine A1and A2Areceptor knockout mice

What makes the a1A-adrenoceptor gene express the a1L-adrenoceptor functional phenotype?

Differential modulation of ATP-induced calcium signalling by A1 and A2 adenosine receptors in cultured cortical astrocytes

Differential involvement of N-type calcium channels in transmitter release from vasoconstrictor and vasodilator neurons

Decreased expression of glial cell line-derived neurotrophic factor signaling in rat models of neuropathic pain

Corrigendum to Halogenation of a capsaicin analogue leads to novel vanilloid TRPVI receptor antagonists

Correlation between spontaneous electrical, calcium and mechanical activity in detrusor smooth muscle of the guinea-pig bladder

Comparison of U46619-, endothelin-1- or phenylephrine-induced changes in cellular Ca2+profiles and Ca2+sensitisation of constriction of pressurised rat resistance arteries

Characterization of the role of endogenous cholecystokinin on the activity of the paraventricular nucleus of the hypothalamus in rats

Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study

Characterisation of the vasorelaxant properties of the novel endocannabinoidN-arachidonoyl-dopamine (NADA)

Changes in the vascularbeta-adrenoceptor-activated signalling pathway in 2Kidney-1Clip hypertensive rats

SHOW MORE ARTICLES

Cannabinoid CB1receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex

[125I]-(Pyr1)Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man

ATP-induced vasodilation in human skeletal muscle

Antiplatelet and antithrombotic effect of F 16618, a new thrombin proteinase-activated receptor-1 (PAR1) antagonist

Antagonism of the antithrombotic and anti-atherosclerotic actions of aspirin by rofecoxib in the cholesterol-fed rabbit

Angiotensin II, a stress-related neuropeptide in the CNS, facilitates micturition reflex in rats

Alpha-1 adrenoceptors: evaluation of receptor subtype-binding kinetics in intact arterial tissues and comparison with membrane binding

Agonist-dependence of recovery from desensitization of P2X3receptors provides a novel and sensitive approach for their rapid up or downregulation

Agonist-activated ion channels

a1-Adrenoceptor subtypes involved in vasoconstrictor responses to exogenous and neurally released noradrenaline in rat femoral resistance arteries

A structural model of agonist binding to thea3beta4 neuronal nicotinic receptor

5-Hydroxytryptamine is biotransformed by CYP2C9, 2C19 and 2B6 to hydroxylamine, which is converted into nitric oxide

FAQs

British Journal of Pharmacology has an SJR of 2,344 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 3429 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for British Journal of Pharmacology is 19%.

British Journal of Pharmacology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of British Journal of Pharmacology?

What is the APC / publication cost?

What is the acceptance rate?